Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma
Author:
Funder
Bartley-Smith/Wharton
Gordon Tozer
Wharton Head and Neck Translational
Dr. Mariano Elia
Petersen-Turofsky Funds
Princess Margaret Foundation
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference19 articles.
1. Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease;Green;Br J Clin Pharmacol,1980
2. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity;Nguyen-Tan;J Clin Oncol,2014
3. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis;O'Sullivan;J Clin Oncol,2013
4. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: a systematic review;Strojan;Head Neck,2016
5. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma;Discover Oncology;2023-12-08
2. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol;PLOS ONE;2023-11-27
3. Practical Application of Circulating Tumor-Related DNA of Human Papillomavirus in Liquid Biopsy to Evaluate the Molecular Response in Patients with Oropharyngeal Cancer;Cancers;2023-02-07
4. Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update;Drugs;2023-01-16
5. The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients;Cancers;2022-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3